Neuroprotection and Traumatic Brain Injury
- 1 October 2001
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 58 (10) , 1553-1555
- https://doi.org/10.1001/archneur.58.10.1553
Abstract
Research from JAMA Neurology — Neuroprotection and Traumatic Brain Injury — The Search ContinuesKeywords
This publication has 14 references indexed in Scilit:
- Failure of the competitive N-methyl-d-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trialsJournal of Neurosurgery, 1999
- Current Status of Neuroprotection Trials for Traumatic Brain Injury: Lessons from Animal Models and Clinical StudiesNeurosurgery, 1999
- Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998Journal of Neurotrauma, 1998
- Activation of CPP32-Like Caspases Contributes to Neuronal Apoptosis and Neurological Dysfunction after Traumatic Brain InjuryJournal of Neuroscience, 1997
- Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trialPublished by American Medical Association (AMA) ,1996
- Pharmacological Treatment of Central Nervous System TraumaBasic & Clinical Pharmacology & Toxicology, 1996
- Development of HU-211 as a neuroprotectant for ischemic brain damageNeurological Research, 1995
- Comparison of Single and Combination Drug Treatment Strategies in Experimental Brain TraumaJournal of Neurotrauma, 1993
- Biochemical changes and secondary injury from stroke and traumaPublished by Elsevier ,1992
- The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain InjuryScience, 1989